SEC: No need for separate Sputnik Light phase-3 trials, Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com

After detailed deliberation, the committee recommended that the firm should present the safety, immunogenicity and efficacy data of Phase-III clinical trial of Sputnik Light that is being carried out in Russia for considering the proposal for grant of MA in the country., After detailed deliberation, the committee recommended that the firm should present the safety, immunogenicity and efficacy data of Phase-III clinical trial of Sputnik Light that is being carried out in Russia for considering the proposal for grant of MA in the country., , Read More